THE ITALIAN REGIONAL ACCESS OF NEW CANCER DRUGS: AN EXAMPLE IN FOUR REGIONS

被引：0
|
作者：
Visentin, E. [1 ]
Heiman, F. [1 ]
Ripellino, C. [1 ]
机构：
[1] IMS Hlth Informat Solut Med Res Srl, Milan, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1296
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN277
引用
收藏
页码：A479 / A479
页数：1
相关论文
共 50 条
  • [1] ITALIAN REGIONAL ACCESS FOR DRUGS: 20 REGIONS VS 21 PROCEDURES
    Prada, M.
    Rossi, L.
    Molchanova, E.
    Mariano, E. E.
    [J]. VALUE IN HEALTH, 2020, 23 : S653 - S653
  • [2] Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
    Gori, Stefania
    Di Maio, Massimo
    Pinto, Carmine
    Alabiso, Oscar
    Baldini, Editta
    Barbato, Enrico
    Beretta, Giordano Domenico
    Bravi, Stefano
    Caffo, Orazio
    Canobbio, Luciano
    Carrozzan, Francesco
    Cinieri, Saverio
    Cruciani, Giorgio
    Dinota, Angelo
    Gebbia, Vittorio
    Giustini, Lucio
    Graiff, Claudio
    Molino, Annamaria
    Muggiano, Antonio
    Pandoli, Giuliano
    Puglisi, Fabio
    Tagliaferri, Pierosandro
    Tomao, Silverio
    Venturini, Marco
    [J]. TUMORI, 2011, 97 (04) : 442 - 448
  • [3] Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions
    Naldi, L
    Conforti, A
    Venegoni, M
    Troncon, MG
    Caputi, A
    Ghiotto, E
    Cocci, A
    Moretti, U
    Velo, G
    Leone, R
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (06) : 839 - 846
  • [4] New cancer drugs: the Italian unsatisfactory solution
    Tartarone, A.
    Lerose, R.
    Aieta, M.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (07) : 1448 - 1448
  • [5] REGIONAL MARKET ACCESS INEQUALITIES FOR NEW ONCOLOGY DRUGS IN SPAIN
    Vieta, A.
    Gimenez, E.
    Badia, X.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A368 - A368
  • [6] Regional multipliers across the Italian regions
    Destefanis, Sergio
    Di Serio, Mario
    Fragetta, Matteo
    [J]. JOURNAL OF REGIONAL SCIENCE, 2022, 62 (04) : 1179 - 1205
  • [7] Advances in Cancer Therapeutics and Patient Access to New Drugs
    George Dranitsaris
    Ilse Truter
    Martie S. Lubbe
    Eitan Amir
    William Evans
    [J]. PharmacoEconomics, 2011, 29 : 213 - 224
  • [8] Balancing Access and Evaluation in the Approval of New Cancer Drugs
    Miller, Franklin G.
    Joffe, Steven
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2345 - 2346
  • [9] New cancer drugs in Sweden: Assessment, implementation and access
    Jonsson, Bengt
    Wilking, Nils
    [J]. JOURNAL OF CANCER POLICY, 2014, 2 (02): : 45 - 62
  • [10] Advances in Cancer Therapeutics and Patient Access to New Drugs
    Dranitsaris, George
    Truter, Ilse
    Lubbe, Martie S.
    Amir, Eitan
    Evans, William
    [J]. PHARMACOECONOMICS, 2011, 29 (03) : 213 - 224
12345